https://www.selleckchem.com/pr....oducts/eribulin-mesy
BACKGROUND AND OBJECTIVES Evidence regarding the impact of sarcopenia on operative outcomes in patients with sarcoma is lacking. We evaluated the relationship between sarcopenia and postoperative complications or mortality among patients undergoing tumor excision and reconstruction. METHODS We retrospectively reviewed 145 patients treated with tumor excision and limb reconstruction for sarcoma of the extremities. Sarcopenia was defined as psoas index (PI) 5 cm vs 77.7%, P = .023). Seventy-three patients experienced compl
Like
Comment
Share
